financetom
FNVT
financetom
/
Financials
/
FNVT
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Finnovate Acquisition Corp.FNVT
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Finnovate Acquisition Corp. does not have significant operations.

The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities.

It intends to focus on the acquisition of Israel-related companies, including companies focused on payments, insuretech, wealthtech, regtech, digital banking, fintech as a service, banking as a service, cyber area for financial institutions, blockchain and crypto, algo-trading and exchanges, and lending and credit line platforms.

Finnovate Acquisition Corp. was incorporated in 2021 and is based in George Town, the Cayman Islands.

Latest News >
Profound Medical Q3 revenue beats estimates
Profound Medical Q3 revenue beats estimates
Nov 13, 2025
Overview * Profound Medical ( PROF ) Q3 revenue up 87% yr/yr, beating analyst expectations * Gross margin increased 1,119 basis points to 74.3% in Q3-2025 * Company reported a net loss of $8 mln, improved from last year Outlook * Profound Medical ( PROF ) expects to reach at least 75 TULSA-PRO installs by year-end Result Drivers * SALES...
Lithium-ion battery maker Expion360 Q3 sales rises
Lithium-ion battery maker Expion360 Q3 sales rises
Nov 13, 2025
Overview * Expion360 Q3 2025 sales grow 72% yr/yr to $2.4 mln, driven by battery demand * Company reports Q3 net income of $0.7 mln, a significant improvement from last year * Expion360 ( XPON ) appoints new CEO and CFO to drive next growth phase Outlook * Company aims to expand OEM market penetration and develop home energy storage...
ORIC Pharmaceuticals Q3 net loss narrows to $32.6 mln
ORIC Pharmaceuticals Q3 net loss narrows to $32.6 mln
Nov 13, 2025
Overview * ORIC Pharmaceuticals ( ORIC ) reports Q3 net loss of $32.6 mln, with decreased operating expenses * Cash and investments of $413 mln expected to fund operations into 2H 2028 Outlook * Company anticipates cash to fund operations into 2H 2028 Result Drivers * LEADERSHIP APPOINTMENT - Appointment of Kevin Brodbeck, PhD, as Chief Technical Officer to support...
Oncology Institute Q3 revenue jumps, partly on organic growth in Florida, Oregon
Oncology Institute Q3 revenue jumps, partly on organic growth in Florida, Oregon
Nov 13, 2025
Overview * Oncology Institute ( TOI ) Q3 revenue rises 36.7% yr/yr, driven by organic growth in Florida, Oregon * Net loss for Q3 widens slightly to $16.5 mln compared to $16.1 mln last year * The cancer clinics operator updates full-year revenue guidance to $495-$505 mln Outlook * Company updates full-year revenue guidance to $495 mln-$505 mln, from prior...
Copyright 2023-2026 - www.financetom.com All Rights Reserved